Cell and Gene Therapy, Cell Therapy
September 16, 2025
dPCR vs. ddPCR: Why Precision Matters in Cell and Gene Therapy
Cell and Gene Therapy, Cell Therapy, Leadership
May 29, 2025
Future Directions for Process Development
Cell and Gene Therapy, Cell Therapy, Leadership
May 05, 2025
Centralized vs. Point-of-Care Manufacturing
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing, Tech Transfer
March 11, 2025
RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter Into a Strategic Partnership to Manufacture FDA Approved Cell Therapy Omisirge® (omidubicel-onlv)
Cell and Gene Therapy, Cell Therapy, Leadership
March 08, 2025
Victoria Gray and the Emily Whitehead Foundation at RoslinCT
![[WEBINAR] Building the Future of Cell based Therapy Trends, Technologies, and Transformations](https://www.roslinct.com/wp-content/uploads/2025/02/Screenshot-2025-02-11-085812-410x231.png)
Cell and Gene Therapy, Cell Therapy
February 11, 2025
[WEBINAR] Building the Future of Cell based Therapy Trends, Technologies, and Transformations
Cell Therapy, Leadership
November 04, 2024
RoslinCT Announces Appointment of Jessica Carmen as Chief Commercial Officer
![[EBOOK] Blog Series: SAB Perspectives](https://www.roslinct.com/wp-content/uploads/2024/10/Blog-post-template-website-407x271-1.jpg)